AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Infliximab in South Africa
2 products registered with SAHPRA — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| REMIFLIX | 53/30.1/0502 | Cipla Medpro (Pty) Ltd | active | 1 Jan 1900 |
| REVELLEX 100 mg | 33/11.10/531 | Janssen Pharmaceutica (Pty) Ltd | active | 1 Jan 1900 |
Infliximab — SAHPRA Registration Details
SAHPRA (South Africa) has 2 registered products containing Infliximab, of which 2 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Infliximab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.